MA19107A1 - Nouveaux derives de 3-(i,piperidinylalkyl)4h-pyrido [i,2-a]-pyridine-4-one . - Google Patents
Nouveaux derives de 3-(i,piperidinylalkyl)4h-pyrido [i,2-a]-pyridine-4-one .Info
- Publication number
- MA19107A1 MA19107A1 MA19313A MA19313A MA19107A1 MA 19107 A1 MA19107 A1 MA 19107A1 MA 19313 A MA19313 A MA 19313A MA 19313 A MA19313 A MA 19313A MA 19107 A1 MA19107 A1 MA 19107A1
- Authority
- MA
- Morocco
- Prior art keywords
- piperidinylalkyl
- pyrido
- pyridine
- derivatives
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13484580A | 1980-03-28 | 1980-03-28 | |
| US06/191,632 US4342870A (en) | 1980-03-28 | 1980-09-29 | Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA19107A1 true MA19107A1 (fr) | 1981-10-01 |
Family
ID=26832744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA19313A MA19107A1 (fr) | 1980-03-28 | 1981-03-21 | Nouveaux derives de 3-(i,piperidinylalkyl)4h-pyrido [i,2-a]-pyridine-4-one . |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4342870A (enEXAMPLES) |
| EP (1) | EP0037265B1 (enEXAMPLES) |
| AU (1) | AU537700B2 (enEXAMPLES) |
| BG (1) | BG36199A3 (enEXAMPLES) |
| CA (1) | CA1163994A (enEXAMPLES) |
| CS (1) | CS256366B2 (enEXAMPLES) |
| DE (1) | DE3168433D1 (enEXAMPLES) |
| DK (1) | DK159390C (enEXAMPLES) |
| ES (1) | ES500814A0 (enEXAMPLES) |
| FI (1) | FI71737C (enEXAMPLES) |
| GR (1) | GR72488B (enEXAMPLES) |
| HU (1) | HU187329B (enEXAMPLES) |
| IE (1) | IE51319B1 (enEXAMPLES) |
| IL (1) | IL62494A (enEXAMPLES) |
| MA (1) | MA19107A1 (enEXAMPLES) |
| NO (1) | NO156752C (enEXAMPLES) |
| NZ (1) | NZ196522A (enEXAMPLES) |
| PH (1) | PH16530A (enEXAMPLES) |
| PT (1) | PT72740B (enEXAMPLES) |
| RO (1) | RO82508A (enEXAMPLES) |
| SU (1) | SU1068037A3 (enEXAMPLES) |
| YU (1) | YU43010B (enEXAMPLES) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4443451A (en) | 1981-07-15 | 1984-04-17 | Janssen Pharmaceutica N.V. | Bicyclic pyrimidin-5-one derivatives |
| US4548938A (en) * | 1981-07-15 | 1985-10-22 | Janssen Pharmaceutica N.V. | 5-H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one compounds |
| US4355037A (en) * | 1981-11-12 | 1982-10-19 | Hoechst-Roussel Pharmaceuticals | 3-(4-Piperidyl)-1,2-benzisoxales |
| US4485107A (en) * | 1982-11-01 | 1984-11-27 | Janssen Pharmaceutica N.V. | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones |
| US4581171A (en) * | 1983-07-27 | 1986-04-08 | Janssen Pharmaceutica, N.V. | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders |
| US4695569A (en) * | 1983-11-30 | 1987-09-22 | Janssen Pharmaceutica N.V. | Bicyclic heterocyclyl containing N-(bicyclic heterocyclyl)-4-piperidinamines |
| US4888426A (en) * | 1983-11-30 | 1989-12-19 | Janssen Pharmaceutica N.V. | 1-(5-methyl-furan-2-ylmethyl)-N-(4-piperidinyl)imidazo [4,5-6]pyridine-2-amine |
| PH23995A (en) * | 1984-01-09 | 1990-02-09 | Janssen Pharmaceutica Nv | 4((bicycle heterocyclyl)-methyl and hetero)piperidines |
| US4548939A (en) * | 1984-10-01 | 1985-10-22 | Janssen Pharmaceutica N. V. | 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones |
| US4804663A (en) * | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| EP0268309B1 (en) * | 1986-09-22 | 1996-12-11 | Janssen Pharmaceutica N.V. | Serotonin antagonists for treating wounds |
| IL90879A0 (en) * | 1988-09-02 | 1990-02-09 | Janssen Pharmaceutica Nv | 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them |
| CA2000786C (en) * | 1988-11-07 | 1999-01-26 | Cornelus G. M. Janssen | 3-piperidinyl-1,2-benzisoxazoles |
| HU207310B (en) * | 1988-12-02 | 1993-03-29 | Pfizer | Process for producing aryl-piperidine derivatives |
| JPH04504263A (ja) * | 1989-03-23 | 1992-07-30 | マリンクロッド・インコーポレイテッド | 放射性沃素又は臭素標識ピペリジン化合物、並びに上記化合物の及び上記化合物を含む組成物の製法 |
| DE4138756A1 (de) * | 1991-11-26 | 1993-05-27 | Troponwerke Gmbh & Co Kg | Kombination mit neuroprotektiver wirkung |
| US5266571A (en) * | 1992-01-09 | 1993-11-30 | Amer Moh Samir | Treatment of hemorrhoids with 5-HT2 antagonists |
| EP0626968B1 (en) * | 1992-02-13 | 2001-09-26 | Merrell Pharmaceuticals Inc. | Piperidinyl thiacyclic derivatives |
| CA2137673C (en) | 1992-07-13 | 2005-09-06 | Jan Vandenberk | Novel 4-[3-benzofuranyl]piperidinyl and 4-[3-benzothienyl]piperidinyl derivatives |
| SI0729357T1 (en) | 1993-11-19 | 2005-06-30 | Janssen Pharmaceutica N.V. | Microencapsulated 1,2-benzazoles |
| ES2085234B1 (es) * | 1994-02-24 | 1997-01-16 | Vita Invest Sa | Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. |
| TW421649B (en) * | 1995-01-31 | 2001-02-11 | Janssen Pharmaceutica Nv | 4-(1H-indol-1yl)-1-piperidinyl derivatives |
| US5753664A (en) * | 1995-03-16 | 1998-05-19 | Takeda Chemical Industries, Ltd. | Heterocyclic compounds, their production and use |
| EP1560814A1 (en) * | 2002-11-13 | 2005-08-10 | Synthon B.V. | Process for making risperidone and intermediates therefor |
| EP1615923A1 (en) * | 2003-04-22 | 2006-01-18 | Synthon B.V. | Risperidone monohydrochloride |
| DK3106166T3 (da) | 2008-02-29 | 2021-01-11 | Vm Therapeutics Llc | Forbindelser til behandling af smertesyndrom og andre lidelser |
| US9586955B2 (en) * | 2012-02-10 | 2017-03-07 | Ptc Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
| EP2819519B1 (en) | 2012-03-01 | 2019-10-23 | PTC Therapeutics, Inc. | Compounds for treating spinal muscular atrophy |
| MX358514B (es) | 2012-03-23 | 2018-08-24 | Ptc Therapeutics Inc | Compuestos para tratar la atrofia muscular espinal. |
| CN105143197A (zh) * | 2013-03-15 | 2015-12-09 | Vm医药有限责任公司 | 新的晶体形式 |
| EP3082820B1 (en) | 2013-12-19 | 2022-07-20 | PTC Therapeutics, Inc. | Methods for modulating the amount of rna transcripts |
| EP3310169B1 (en) | 2015-05-30 | 2023-05-17 | PTC Therapeutics, Inc. | Methods for modulating rna splicing |
| CN113717154B (zh) | 2015-12-10 | 2024-11-15 | Ptc医疗公司 | 用于治疗亨廷顿病的方法 |
| CA3043755A1 (en) | 2016-11-28 | 2018-05-31 | Ptc Therapeutics, Inc. | Methods for modulating rna splicing |
| CN111065626B (zh) | 2017-06-05 | 2024-09-27 | Ptc医疗公司 | 用于治疗亨廷顿氏舞蹈病的化合物 |
| CA3065547A1 (en) | 2017-06-14 | 2018-12-20 | Ptc Therapeutics, Inc. | Methods for modifying rna splicing |
| EP3644996B1 (en) | 2017-06-28 | 2023-07-26 | PTC Therapeutics, Inc. | Methods for treating huntington's disease |
| BR112019027719A2 (pt) | 2017-06-28 | 2020-07-28 | Ptc Therapeutics, Inc. | métodos para tratar a doença de huntington |
| MX2020009957A (es) | 2018-03-27 | 2021-01-15 | Ptc Therapeutics Inc | Compuestos para el tratamiento de enfermedad de hungtinton. |
| FI3814357T3 (fi) | 2018-06-27 | 2024-07-26 | Ptc Therapeutics Inc | Heterosykliset ja heteroaryliyhdisteet huntingtonin taudin hoitoon |
| CA3104516A1 (en) | 2018-06-27 | 2020-01-02 | Ptc Therapeutics, Inc. | Heteroaryl compounds for treating huntington's disease |
| EP3814360B8 (en) | 2018-06-27 | 2024-11-06 | PTC Therapeutics, Inc. | Heteroaryl compounds for treating huntington's disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3412094A (en) * | 1967-06-21 | 1968-11-19 | Searle & Co | 5-alkyl-2-amino-4-azido-6-phenylpyrimidines and congeners |
| US3960863A (en) * | 1974-06-25 | 1976-06-01 | Sankyo Company Limited | Pyrido[1,2-a]pyrimidinone derivatives |
| JPS5146497A (en) * | 1974-10-19 | 1976-04-20 | Masato Aiura | Hobuban |
| JPS525795A (en) * | 1975-06-28 | 1977-01-17 | Sankyo Co Ltd | Preparation of tetrahydro pyridopyrimidinone derivatives |
| HU173438B (hu) * | 1975-11-27 | 1979-05-28 | Chinoin Gyogyszer Es Vegyeszet | Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom |
-
1980
- 1980-09-29 US US06/191,632 patent/US4342870A/en not_active Expired - Lifetime
-
1981
- 1981-03-03 GR GR64291A patent/GR72488B/el unknown
- 1981-03-04 CA CA000372258A patent/CA1163994A/en not_active Expired
- 1981-03-17 AU AU68429/81A patent/AU537700B2/en not_active Ceased
- 1981-03-17 NZ NZ196522A patent/NZ196522A/en unknown
- 1981-03-21 MA MA19313A patent/MA19107A1/fr unknown
- 1981-03-24 SU SU813261927A patent/SU1068037A3/ru active
- 1981-03-24 CS CS812134A patent/CS256366B2/cs unknown
- 1981-03-26 IL IL62494A patent/IL62494A/xx unknown
- 1981-03-26 PT PT72740A patent/PT72740B/pt not_active IP Right Cessation
- 1981-03-26 DK DK138281A patent/DK159390C/da not_active IP Right Cessation
- 1981-03-26 PH PH25429A patent/PH16530A/en unknown
- 1981-03-27 HU HU81783A patent/HU187329B/hu not_active IP Right Cessation
- 1981-03-27 ES ES500814A patent/ES500814A0/es active Granted
- 1981-03-27 DE DE8181301335T patent/DE3168433D1/de not_active Expired
- 1981-03-27 YU YU810/81A patent/YU43010B/xx unknown
- 1981-03-27 EP EP81301335A patent/EP0037265B1/en not_active Expired
- 1981-03-27 NO NO811058A patent/NO156752C/no unknown
- 1981-03-27 BG BG051433A patent/BG36199A3/xx unknown
- 1981-03-27 FI FI810956A patent/FI71737C/fi not_active IP Right Cessation
- 1981-03-27 IE IE706/81A patent/IE51319B1/en not_active IP Right Cessation
- 1981-03-28 RO RO81103848A patent/RO82508A/ro unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU6842981A (en) | 1981-10-01 |
| NO156752C (no) | 1987-11-18 |
| YU43010B (en) | 1989-02-28 |
| RO82508B (ro) | 1983-08-30 |
| HU187329B (en) | 1985-12-28 |
| FI810956L (fi) | 1981-09-29 |
| EP0037265B1 (en) | 1985-01-23 |
| RO82508A (ro) | 1983-09-26 |
| PT72740A (en) | 1981-04-01 |
| AU537700B2 (en) | 1984-07-05 |
| FI71737B (fi) | 1986-10-31 |
| IL62494A (en) | 1984-08-31 |
| FI71737C (fi) | 1987-02-09 |
| IE810706L (en) | 1981-09-28 |
| CA1163994A (en) | 1984-03-20 |
| NZ196522A (en) | 1985-10-11 |
| CS256366B2 (en) | 1988-04-15 |
| PT72740B (en) | 1982-11-16 |
| NO811058L (no) | 1981-09-29 |
| DK159390B (da) | 1990-10-08 |
| GR72488B (enEXAMPLES) | 1983-11-14 |
| BG36199A3 (en) | 1984-09-14 |
| IE51319B1 (en) | 1986-12-10 |
| DE3168433D1 (de) | 1985-03-07 |
| SU1068037A3 (ru) | 1984-01-15 |
| IL62494A0 (en) | 1981-05-20 |
| NO156752B (no) | 1987-08-10 |
| US4342870A (en) | 1982-08-03 |
| EP0037265A1 (en) | 1981-10-07 |
| ES8300763A1 (es) | 1982-11-01 |
| ES500814A0 (es) | 1982-11-01 |
| PH16530A (en) | 1983-11-10 |
| DK138281A (da) | 1981-09-29 |
| YU81081A (en) | 1983-12-31 |
| DK159390C (da) | 1991-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA19107A1 (fr) | Nouveaux derives de 3-(i,piperidinylalkyl)4h-pyrido [i,2-a]-pyridine-4-one . | |
| MX9203592A (es) | Derivados de sulfamoil-fenetilamina substituida. | |
| FI801229A7 (fi) | 4-amino-3-karboksi- tai syano-1,2- dihydro-2-okso-1,8- naftyridiinijohdannaisia. | |
| FI831437A7 (fi) | 2-fenyyli-imidatso/4,5-c/pyridiinejä. | |
| FI810921A7 (fi) | Imidatsopyridiinejä. | |
| ATE33651T1 (de) | Imidazo(1,5-a)pyridin-derivate. | |
| FI864891A7 (fi) | Foerfarande foer framstaellning av 6,7,8,9-tetrahydro-10-metylpyrido/1,2-a/indol-9-aminer och deras derivat. | |
| FI801464A7 (fi) | Foerfarande foer framstaellning av substituerade pyrido/1,2-a/pyrimidiner | |
| FI792850A7 (fi) | Auronijohdannaisia. | |
| FI864003A7 (fi) | Pyrido /1,2-a/ pyrimidinderivat, foerfaranden foer framstaellning daerav och dessa innehaollande farmaceutiska kompositioner foer behandling av allergiska sjukdomar. | |
| FI811967A7 (fi) | 2,3-bis-hydroksibentsyylijohdannaisia. | |
| DE3682244D1 (de) | Substituierte dihydroimidazo(1,2-a)chinoxalinderivate. | |
| DE3267918D1 (de) | Pyrazolo(3,4-b)pyridine derivatives | |
| FI802318A7 (fi) | 6-alkyyli-7-fenyyli-1,6-naftyridiini- 5(gH)-oni-johdannaisia. | |
| IT7924171A0 (it) | Imidazoliletossi-derivati di pirazol-aperta parentesi quadra 3,4-b chiusa parentesi quadra-piridin-5-metanoli. | |
| FI874400A7 (fi) | Foerfarande foer framstaellning av imidazo-4,5-b pyridin-2-on-derivat. | |
| FI813757L (fi) | Nytt foerfarande foer framstaellning av imidazo/4,5-b/pyridiner och -pyrimidiner | |
| NO884788L (no) | Nye rifamycin-derivater. | |
| FI872073A0 (fi) | Derivat av propargyloxybenzener, deras framstaellning och fungicida sammansaettningar i vilka de ingaor. | |
| FI870253A7 (fi) | Foerfarande foer framstaellning av 1-acylaminometyl-imidazo/1,2-a/kinolinderivat. | |
| FI865344A7 (fi) | Foerfarande foer framstaellning av pyrimido/5,4-b//1,4/oxazinderivat. | |
| DE3578177D1 (de) | 4,7-dihydropyrazolo(3,4-b)pyridin-derivate. | |
| FI841221L (fi) | 7,8,9,10-tetrahydrotieno/3,2- e/pyrido/4,3-b/indoler, foerfarande foer deras framstaellning och dessa innehaollande laekemedel. | |
| BE889048A (fr) | Derives de methyl-quinoxaline-1,4-dioxyde | |
| ATE11415T1 (de) | 3-(1-piperidinylalkyl)-4h-pyrido(1,2-a)pyrimidi - 4-on-derivate. |